Screener
Evolent Health, Inc. EVH EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Evolent Health, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Evolent Health, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:53 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628908-26-000086
FAQ
- What is Evolent Health, Inc.'s EBITDA margin?
- Evolent Health, Inc. (EVH) reported EBITDA margin of -15.1% in Q2 2026.
- How has Evolent Health, Inc.'s EBITDA margin changed year-over-year?
- Evolent Health, Inc.'s EBITDA margin decreased by 582.4% year-over-year, from 3.1% to -15.1%.
- What is the long-term trend for Evolent Health, Inc.'s EBITDA margin?
- Over 5 years (2020 to 2025), Evolent Health, Inc.'s EBITDA margin has grown at a -6.8% compound annual growth rate (CAGR), from -22.3% to -15.7%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.
Ask your AI about Evolent Health, Inc.'s ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude